Glenn Coleman insider trades: Charles River Laboratories International (CRL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Glenn reports to the SEC
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | CRL | ↑ Buy | 10 | $297.43 | $3K | Direct | Oct 2, 2026 (2d) |
| Nov 20, 2023 | XRAY | ↑ Buy | 10,000 | $29.70 | $297K | Direct | Nov 20, 2023 (0d) |
| Apr 4, 2022 | IART | ↓ Sell10b5-1 | 6,268 | $66.04 | $414K | Direct | Apr 6, 2022 (2d) |
| Nov 2, 2021 | IART | ↓ Sell | 4,275 | $74.00 | $316K | Direct | Nov 3, 2021 (1d) |
| Apr 16, 2021 | IART | ↓ Sell | 25,658 | $71.50 | $1.8M | Direct | Apr 19, 2021 (3d) |
| Apr 14, 2021 | IART | ↓ Sell | 4,002 | $70.50 | $282K | Direct | Apr 15, 2021 (1d) |
| Apr 9, 2021 | IART | ↓ Sell | 12,500 | $70.00 | $875K | Direct | Apr 12, 2021 (3d) |
| Mar 29, 2021 | IART | ↓ Sell | 15,500 | $68.50 | $1.1M | Direct | Mar 30, 2021 (1d) |
| Nov 13, 2020 | IART | ↓ Sell | 2,600 | $56.03 | $146K | Direct | Nov 17, 2020 (4d) |
| Nov 9, 2020 | IART | ↓ Sell | 9,400 | $55.15 | $518K | Direct | Nov 12, 2020 (3d) |
| Aug 11, 2020 | IART | ↓ Sell10b5-1 | 5,000 | $52.27 | $261K | Direct | Aug 13, 2020 (2d) |
| Jul 24, 2019 | IART | ↓ Sell | 3,500 | $57.50 | $201K | Direct | Jul 26, 2019 (2d) |
| Jun 28, 2019 | IART | ↓ Sell | 3,650 | $55.00 | $201K | Direct | Jul 2, 2019 (4d) |
| Aug 9, 2018 | IART | ↓ Sell | 8,916 | $63.00 | $562K | Direct | Aug 10, 2018 (1d) |
| Mar 14, 2018 | IART | ↓ Sell | 8,769 | $56.10 | $492K | Direct | Mar 15, 2018 (1d) |
| May 4, 2017 | IART | ↓ Sell | 13,865 | $45.91 | $637K | Direct | May 5, 2017 (1d) |
| Mar 15, 2017 | IART | ↓ Sell | 4,462 | $43.19 | $193K | Direct | Mar 17, 2017 (2d) |
| May 4, 2016 | IART | ↓ Sell | 3,563 | $70.62 | $252K | Direct | May 6, 2016 (2d) |
| May 12, 2014 | CW | ↓ Sell | 13,249 | $69.41 | $920K | Direct | May 14, 2014 (2d) |
| Mar 20, 2014 | CW | ↓ Sell | 829 | $62.37 | $52K | Direct | Mar 24, 2014 (4d) |
| Nov 18, 2013 | CW | ↓ Sell | 739 | $51.30 | $38K | Direct | Nov 19, 2013 (1d) |
| Nov 5, 2013 | CW | ↓ Sell | 475 | $50.55 | $24K | Direct | Nov 7, 2013 (2d) |
| Nov 5, 2013 | CW | ↓ Sell | 475 | $50.55 | $24K | Direct | Nov 7, 2013 (2d) |
| Aug 5, 2013 | CW | ↓ Sell | 714 | $44.19 | $32K | Direct | Aug 5, 2013 (0d) |
| May 20, 2013 | CW | ↓ Sell | 347 | $36.77 | $13K | Direct | May 21, 2013 (1d) |
| Apr 2, 2013 | CW | ↓ Sell | 791 | $33.68 | $27K | Direct | Apr 3, 2013 (1d) |
| Mar 13, 2013 | CW | ↓ Sell | 374 | $34.81 | $13K | Direct | Mar 15, 2013 (2d) |
| Nov 19, 2012 | CW | ↓ Sell | 648 | $29.87 | $19K | Direct | Nov 20, 2012 (1d) |
| Nov 14, 2012 | CW | ↓ Sell | 735 | $29.68 | $22K | Direct | Nov 16, 2012 (2d) |
| Mar 27, 2012 | CW | ↓ Sell | 679 | $37.88 | $26K | Direct | Mar 29, 2012 (2d) |
| Feb 24, 2012 | CW | ↓ Sell | 282 | $38.00 | $11K | Direct | Feb 27, 2012 (3d) |
| Nov 16, 2011 | CW | ↓ Sell | 583 | $33.04 | $19K | Direct | Nov 17, 2011 (1d) |
| Nov 15, 2011 | CW | ↓ Sell | 503 | $31.86 | $16K | Direct | Nov 16, 2011 (1d) |
| Feb 17, 2011 | CW | ↓ Sell | 448 | $37.46 | $17K | Direct | Feb 18, 2011 (1d) |
| Jan 14, 2009 | CW | ↑ Buy | 448 | $27.90 | $13K | Direct | Jan 16, 2009 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRL insiders
Open-market trades in the last 12 months
About Glenn Coleman's insider trades
Glenn Coleman is EVP & Chief Financial Officer at Charles River Laboratories International (CRL). Since Jan 14, 2009, Glenn has reported 3 open-market purchases worth $312K and 32 sales worth $9.5M on SEC Form 4. In the last 12 months: 1 buy ($3K).
2 sales (7% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (55 filings), shares withheld for taxes (19 filings), option exercises (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.